Explore evidence

95.7 %In 2022, virologic suppression at less than 1000 copies/ml was 95.7% among persons with HIV who initiated ART between January 2016 and September 2022 in Nigeria.

NigeriaVIH/sidaobserved 2022published 2023AIDS (London, England)PubMeddocument of 4 observations

75.3 %Among HIV-infected women attending a tertiary health facility in Kano, Nigeria, 75.3% were aware of their transmission risk during delivery.

NigeriaVIH/sidapublished 2019International journal of health policy and managementPubMeddocument of 10 observations

82 %Most respondents knew that posttest counselling of HIV-negative women was necessary (82%).

NigeriaVIH/sidapublished 2022BMC health services researchPubMeddocument of 6 observations

0 %The mother-to-child transmission (MTCT) rate for HIV, HBV, and HCV among pregnant women in Nigeria was 0% at 6-week post-delivery.

Nigeriahépatite B · hépatite C · VIH/sidaobserved 6-week post-deliverypublished 2025Antiviral therapyPubMeddocument of 7 observations

8.4 %In health facilities in Benue State, Nigeria during a similar time period, 8.4% of pregnant women had a HIV-positive status.

NigeriaVIH/sidaobserved similar time periodpublished 2021PloS onePubMeddocument of 11 observations

7.5 %Pregnant women with HIV infection had a prevalence of HTLV-1/-2 infection of 7.5%, compared to 11.7% among those without HIV infection.

NigeriaHTLV-1/-2 · VIH/sidapublished 2021Human antibodiesPubMeddocument of 5 observations

17.2 %The overall rate of mother-to-child transmission (MTCT) of HIV infection was 17.2%.

NigeriaVIH/sidapublished 2020Malaria journalPubMeddocument of 5 observations

1.55 %The overall HIV positivity rate in Nigeria was 1.55%.

NigeriaVIH/sidaobserved 2018published 2021Annals of global healthPubMeddocument of 12 observations

50.8 %50.8% of sexual minority men self-reported antiretroviral therapy non-adherence.

NigeriaVIH/sidaobserved 2014published 2024AIDS carePubMeddocument of 2 observations

37.9 %Candida species were isolated in 195 (37.9%) of 514 HIV-positive patients in southeast Nigeria.

Nigeriaoral candidiasis · VIH/sidapublished 2026BMC infectious diseasesPubMeddocument of 11 observations

74 %Among people living with HIV/AIDS initiating antiretroviral treatment, 6-month retention increased from 74% to 92% during February–September 2020.

NigeriaVIH/sidaobserved February–September 2020published 2021AIDS research and therapyPubMeddocument of 6 observations

3.8 %HIV seropositivity was observed in 51 (3.8%) of 1329 patients enrolled for haemodialysis between 2019 and 2022 in four public dialysis centres in Kano and Jigawa state, Northwest Nigeria.

NigeriaVIH/sidaobserved 2019–2022published 2023The Nigerian postgraduate medical journalPubMeddocument of 10 observations

6 casesAmong 163 pregnant women retested in labor who previously tested HIV negative in antenatal clinic, 6 demonstrated HIV seroconversion.

NigeriaVIH/sidaobserved October 2015 to March 2016published 2019Nigerian journal of clinical practicePubMeddocument of 3 observations

1.6 %113 (1.6%) of the 7,034 HIV-infected patients assessed at the PEPFAR outpatient clinic at Lagos University Teaching Hospital between April 2004 and February 2016 were known to have died.

NigeriaVIH/sidaobserved April 2004-February 2016published 2020African health sciencesPubMeddocument of 12 observations

25.9 %G/CRF02_AG accounted for 25.9% of HIV-1 cases.

NigeriaVIH/sidaobserved 2009-12published 2016PloS onePubMeddocument of 14 observations

18 individualsAmong the 30 selected young people living with HIV, 18 had viral load suppression during the first test.

NigeriaVIH/sidapublished 2023BMJ global healthPubMeddocument of 4 observations

81.1 %81.1% of participants exhibited satisfactory attitudes toward antiretroviral therapy.

NigeriaVIH/sidapublished 2025BMC public healthPubMeddocument of 6 observations

19,356 tests_per_monthThe average number of monthly HIV tests was 19,356 in the pre-transition period.

NigeriaVIH/sidapublished 2025BMC health services researchPubMeddocument of 9 observations

0.6 %Dual seropositivity of anti-hepatitis C virus/anti-HIV among pregnant women in Nigeria accounted for 0.6%.

Nigeriahépatite C · VIH/sidapublished 2021Women's health (London, England)PubMeddocument of 7 observations

95 %The national target for HIV testing during pregnancy in Nigeria is 95%.

NigeriaVIH/sidapublished 2021Journal of public health (Oxford, England)PubMeddocument of 3 observations

93 %Between July 2016 and October 2017, 93.0% of HIV-positive pregnant women identified at Baby Shower events in Benue State, Nigeria were linked to antiretroviral therapy.

NigeriaVIH/sidaobserved July 2016 to October 2017published 2021PloS onePubMeddocument of 11 observations

1 infectionOnly one recent infection was detected in the study population.

NigeriaVIH/sidapublished 2022AIDS (London, England)PubMeddocument of 4 observations

15.3 %At repeat evaluation, the proportion of type B tympanogram was 15.3% in the right ear and 14% in the left ear among 150 HIV-positive patients.

NigeriaVIH/sidapublished 2023Nigerian journal of clinical practicePubMeddocument of 6 observations

57.3 %57.3% of respondents cited fear of rejection by other people as the main reason for non-disclosure.

NigeriaVIH/sidapublished 2022The Pan African medical journalPubMeddocument of 12 observations

82 per_weekDuring May 2019–September 2020, the weekly number of newly diagnosed people living with HIV (PWH) initiated on antiretroviral therapy (ART) supported by PEPFAR in Rivers State increased from 82 to 1723.

NigeriaVIH/sidaobserved May 2019–September 2020published 2021AIDS (London, England)PubMeddocument of 3 observations